Sunmax Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,147	711.59	775.47	854.69	589.3	602.55
Short-Term Investments	-	250	90	107.1	227.37	76.79
Cash & Short-Term Investments	1,147	961.59	865.47	961.79	816.67	679.34
Cash Growth	1.79%	11.11%	-10.02%	17.77%	20.21%	-25.31%
Accounts Receivable	1.96	2.21	2.54	2.55	1.94	3.72
Other Receivables	0.72	0.72	26.07	6.84	1.37	4.71
Receivables	2.68	2.93	28.61	9.39	3.3	8.43
Inventory	171.74	152.66	157.36	93.67	73.79	54.74
Other Current Assets	73.51	25.9	41.08	14.08	11.81	45.06
Total Current Assets	1,395	1,143	1,093	1,079	905.58	787.57
Property, Plant & Equipment	918.23	911.64	939.2	904.32	604.39	485.56
Long-Term Investments	-	-	-	-	10.3	17.18
Other Intangible Assets	9.02	9.75	6.4	5.06	3.84	3.84
Long-Term Deferred Tax Assets	31.37	28.89	37.71	53.39	20.76	17.32
Other Long-Term Assets	28.81	30	19.15	117.33	248.41	172.55
Total Assets	2,383	2,123	2,095	2,159	1,793	1,484
Accounts Payable	14.08	7.25	18.27	11.98	21.77	14.95
Current Portion of Leases	33.82	25.47	23.28	24.24	13.27	32.28
Current Income Taxes Payable	153.86	72.08	67.76	89.03	82.94	70.84
Current Unearned Revenue	47.17	22.05	73.85	202.57	60.09	122.95
Other Current Liabilities	795.75	166.91	145.75	129.62	147.93	92.93
Total Current Liabilities	1,045	293.76	328.91	457.43	326	333.95
Long-Term Leases	82.23	93.87	121.94	144.78	49.82	66.9
Long-Term Deferred Tax Liabilities	41.89	91.02	103.06	105.19	57.16	22.16
Other Long-Term Liabilities	27.81	26.95	28.23	25.59	35.02	37.43
Total Liabilities	1,197	505.6	582.13	732.99	468	460.44
Common Stock	544.63	544.63	544.63	544.63	544.63	544.63
Additional Paid-In Capital	3.65	3.65	3.65	3.65	3.65	25.44
Retained Earnings	629.68	1,067	973.11	892.8	778.61	460.46
Comprehensive Income & Other	8.28	2.39	-8.56	-15.04	-1.62	-6.95
Shareholders' Equity	1,186	1,618	1,513	1,426	1,325	1,024
Total Liabilities & Equity	2,383	2,123	2,095	2,159	1,793	1,484
Total Debt	116.04	119.33	145.21	169.02	63.09	99.18
Net Cash (Debt)	1,031	842.26	720.26	792.78	753.58	580.16
Net Cash Growth	4.41%	16.94%	-9.15%	5.20%	29.89%	-25.59%
Net Cash Per Share	18.95	15.44	13.21	14.54	13.82	10.64
Filing Date Shares Outstanding	55.4	54.46	54.46	54.46	54.46	54.46
Total Common Shares Outstanding	55.4	54.46	54.46	54.46	54.46	54.46
Working Capital	350.75	849.33	763.6	621.51	579.57	453.62
Book Value Per Share	21.41	29.70	27.78	26.18	24.33	18.79
Tangible Book Value	1,177	1,608	1,506	1,421	1,321	1,020
Tangible Book Value Per Share	21.25	29.52	27.66	26.09	24.26	18.72
Land	-	64.9	64.9	-	-	-
Buildings	-	522.47	517.01	487.13	482.71	-
Machinery	-	343.9	343.25	293.4	82.42	62.95
Construction In Progress	-	3.99	0.3	17.79	-	331.26
Leasehold Improvements	-	23.46	45.44	44.01	44.79	44.4